Skip to search formSkip to main contentSkip to account menu

Power mobility device, not coded by dme pdac or does not meet criteria

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract C19: The role of resident liver macrophages in suppressing the progression of hepatic micrometastases from pancreatic ductal adenocarcinoma
Background: The majority of patients with localized pancreatic ductal adenocarcinoma (PDAC) die from metastatic disease… 
2015
2015
Abstract B18: MicroRNA-21 is involved in pancreatic cancer fibroblast tumor supportiveness
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by poor survival despite current medical and surgical… 
2015
2015
Accuracy of pre-surgical evaluation in patients with suspected pancreatic malignancy
2014
2014
Solid-pseudopapillary neoplasm (SPN) of the pancreas: An enigmatic entity
2013
2013
Structural imaging of the pancreas in rat using micro-CT: application to a non-invasive longitudinal evaluation of pancreatic ductal carcinoma monitoring
The aim of the study was to evaluate the feasibility of a longitudinal non-invasive monitoring of rat pancreatic ductal… 
2013
2013
Efemp1 and p27Kip1 modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models
Pancreatic ductal adenocarcinoma (PDAC) remains a dismal disease with a poor prognosis and targeted therapies have failed in the… 
2012
2012
Abstract A2: Autoantibody signature in pancreatic ductal adenocarcinoma.
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized by rapid progression, invasiveness and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)